Memory B cell resurgence requires repeated rituximab in myasthenia gravis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Memory B cell resurgence requires repeated rituximab in myasthenia gravis

Published:2017-10 Issue:10 Volume:27 Page:918-922
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Muto Kohei,Matsui Naoko,Unai Yuki,Sakai Waka,Haji Shotaro,Udaka Kengo,Miki Hirokazu,Furukawa Takahiro,Abe Masahiro,Kaji Ryuji

Funder

Ministry of Health, Labour and Welfare, Japan

Publisher

Elsevier BV

Subject

Genetics(clinical),Clinical Neurology,Neurology,Pediatrics, Perinatology, and Child Health

Reference24 articles.

1. Myasthenia gravis;Vincent;Lancet,2001

2. Japanese clinical guidelines for myasthenia gravis: putting into practice;Murai;Clin Exp Neuroimmunol,2015

3. Steroids and immunosuppressant drugs in myasthenia gravis;Sathasivam;Nat Clin Pract Neurol,2008

4. Myasthenia gravis: five new things;Statland;Neurol Clin Pract,2013

5. When the patient fails to respond to treatment: myasthenia gravis;Hilton-Jones;Pract Neurol,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis;Frontiers in Immunology;2024-06-06

2. The rate of QMGS change predicts recurrence after thymectomy in myasthenia gravis;Journal of Clinical Neuroscience;2024-06

3. B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis;Frontiers in Immunology;2024-04-22

4. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease;Frontiers in Immunology;2023-07-26

5. The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome;Multiple Sclerosis and Related Disorders;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3